Hazel Rogers

4.5k total citations
16 papers, 355 citations indexed

About

Hazel Rogers is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Hazel Rogers has authored 16 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 3 papers in Neurology. Recurrent topics in Hazel Rogers's work include Glioma Diagnosis and Treatment (7 papers), Hedgehog Signaling Pathway Studies (3 papers) and Epigenetics and DNA Methylation (3 papers). Hazel Rogers is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Hedgehog Signaling Pathway Studies (3 papers) and Epigenetics and DNA Methylation (3 papers). Hazel Rogers collaborates with scholars based in United Kingdom, United States and Germany. Hazel Rogers's co-authors include Richard G. Grundy, Peter S. Sebel, P. J. Flynn, D A Ingram, Beth Coyle, James Lowe, S. Miller, Jennifer H. Ward, Steven C. Clifford and John‐Paul Kilday and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Hazel Rogers

16 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hazel Rogers United Kingdom 11 187 128 56 54 45 16 355
Michel Sourour Canada 6 644 3.4× 71 0.6× 104 1.9× 23 0.4× 26 0.6× 7 797
Masaki Hirano Japan 11 98 0.5× 151 1.2× 42 0.8× 46 0.9× 61 1.4× 29 332
Paola Suárez-Meade United States 11 109 0.6× 228 1.8× 59 1.1× 77 1.4× 64 1.4× 34 466
Kedar Mahajan United States 12 113 0.6× 61 0.5× 21 0.4× 98 1.8× 29 0.6× 24 557
Lina Marenco-Hillembrand United States 9 80 0.4× 200 1.6× 52 0.9× 68 1.3× 53 1.2× 24 390
Kenzo Kosugi Japan 11 52 0.3× 110 0.9× 61 1.1× 112 2.1× 21 0.5× 40 398
C. Fernández-Carballal Spain 8 199 1.1× 50 0.4× 23 0.4× 77 1.4× 153 3.4× 14 341
Suvi Larjavaara Finland 5 68 0.4× 176 1.4× 16 0.3× 58 1.1× 39 0.9× 7 347
Daria Krivosheya United States 8 64 0.3× 125 1.0× 31 0.6× 29 0.5× 25 0.6× 13 284
Atsushi Isshiki Japan 9 181 1.0× 18 0.1× 49 0.9× 19 0.4× 73 1.6× 18 445

Countries citing papers authored by Hazel Rogers

Since Specialization
Citations

This map shows the geographic impact of Hazel Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel Rogers more than expected).

Fields of papers citing papers by Hazel Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel Rogers. The network helps show where Hazel Rogers may publish in the future.

Co-authorship network of co-authors of Hazel Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel Rogers. A scholar is included among the top collaborators of Hazel Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel Rogers. Hazel Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ritzmann, Timothy, Hazel Rogers, Simon Paine, et al.. (2020). A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups. Pediatric Blood & Cancer. 67(9). e28426–e28426. 27 indexed citations
2.
Rogers, Hazel, Rebecca Chapman, Julie Allard, et al.. (2018). Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma. Oncotarget. 9(92). 36530–36541. 6 indexed citations
3.
Ritzmann, Timothy, Hazel Rogers, Andrew M. Donson, et al.. (2018). EPEN-09. RNA-SEQ ANALYSIS OF RECURRENT PAEDIATRIC EPENDYMOMAS REVEALS IMMUNOLOGICAL CHANGES SPECIFIC TO MOLECULAR SUBGROUPS. Neuro-Oncology. 20(suppl_2). i75–i75. 1 indexed citations
4.
Rogers, Hazel, et al.. (2016). The therapeutic potential of targeting the PI3K pathway in pediatric brain tumors. Oncotarget. 8(2). 2083–2095. 17 indexed citations
5.
Rogers, Hazel, et al.. (2013). PI3K Pathway Activation Provides a Novel Therapeutic Target for Pediatric Ependymoma and Is an Independent Marker of Progression-Free Survival. Clinical Cancer Research. 19(23). 6450–6460. 14 indexed citations
6.
Henriquez, Nico V., Tim Forshew, Ruth Tatevossian, et al.. (2013). Comparative Expression Analysis Reveals Lineage Relationships between Human and Murine Gliomas and a Dominance of Glial Signatures during Tumor Propagation In Vitro. Cancer Research. 73(18). 5834–5844. 24 indexed citations
7.
Rogers, Hazel, Jennifer H. Ward, S. Miller, et al.. (2013). The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs). British Journal of Cancer. 108(10). 2130–2141. 13 indexed citations
8.
Rogers, Hazel, Susana R. Sousa, Carmen Saltó, et al.. (2012). WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma. British Journal of Cancer. 107(7). 1144–1152. 18 indexed citations
9.
Miller, S., Jennifer H. Ward, Hazel Rogers, James Lowe, & Richard G. Grundy. (2012). Loss of INI1 Protein Expression Defines a Subgroup of Aggressive Central Nervous System Primitive Neuroectodermal Tumors. Brain Pathology. 23(1). 19–27. 18 indexed citations
10.
Miller, S., Hazel Rogers, Paul Lyon, et al.. (2011). Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma. Neuro-Oncology. 13(8). 866–879. 47 indexed citations
11.
Rogers, Hazel, John‐Paul Kilday, Jennifer H. Ward, et al.. (2011). Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death. Acta Neuropathologica. 123(5). 711–725. 29 indexed citations
12.
Rogers, Hazel, S. Miller, James Lowe, et al.. (2009). An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET). British Journal of Cancer. 100(8). 1292–1302. 31 indexed citations
13.
Messmann, Richard A., R. J. Amato, Joan Hernandez-McClain, et al.. (2007). A phase II study of FolateImmune (EC90 with GP1–0100 adjuvant followed by EC17) with low dose cytokines interleukin-2 (IL-2) and interferon-α (IFN-α) in patients with refractory or metastatic cancer. Journal of Clinical Oncology. 25(18_suppl). 13516–13516. 7 indexed citations
14.
Waxman, Jonathan, Claire Barton, Nicholas D. James, et al.. (1992). Bladder Cancer: Inter‐relationships between Chemotherapy and Radiotherapy. British Journal of Urology. 69(2). 151–155. 5 indexed citations
15.
Sebel, Peter S., et al.. (1987). Evoked Potentials During Isoflurane Anesthesia. Survey of Anesthesiology. 31(1). 15–15. 3 indexed citations
16.
Sebel, Peter S., et al.. (1986). EVOKED POTENTIALS DURING ISOFLURANE ANAESTHESIA. British Journal of Anaesthesia. 58(6). 580–585. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Sourour Breakdown of academic impact, for papers by Masaki Hirano Breakdown of academic impact, for papers by Paola Suárez-Meade Breakdown of academic impact, for papers by Kedar Mahajan Breakdown of academic impact, for papers by Lina Marenco-Hillembrand Breakdown of academic impact, for papers by Kenzo Kosugi Breakdown of academic impact, for papers by C. Fernández-Carballal Breakdown of academic impact, for papers by Suvi Larjavaara Breakdown of academic impact, for papers by Daria Krivosheya Breakdown of academic impact, for papers by Atsushi Isshiki
Rankless by CCL
2026